Abbott (ABT) Tops Q3 EPS by 1c; Narrows, Boosts FY16 EPS Outlook

Abbott (NYSE: ABT) reported Q3 EPS of $0.59, $0.01 better than the analyst estimate of $0.58. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.29 billion.

GUIDANCE:

Abbott sees FY2016 EPS of $2.19 - $2.21, versus prior guidance of $2.14 - $2.24 and the consensus of $2.20.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Baird Starts Abbott Labs (ABT) at Outperform, 'Set to Improve with Catalysts Ahead'
• Biogen expects $164M R&D charge to hit Q2 2026 earnings
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform